Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Teva
Express Scripts
Fuji
Johnson and Johnson
AstraZeneca
Medtronic
McKesson
Fish and Richardson
Dow

Generated: January 19, 2018

DrugPatentWatch Database Preview

ELIXOPHYLLIN Drug Profile

« Back to Dashboard

When do Elixophyllin patents expire, and what generic alternatives are available?

Elixophyllin is a drug marketed by Forest Labs and Nostrum Labs Inc and is included in four NDAs.

The generic ingredient in ELIXOPHYLLIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Drug patent expirations by year for ELIXOPHYLLIN
Pharmacology for ELIXOPHYLLIN
Ingredient-typeXanthines
Drug ClassMethylxanthine

US Patents and Regulatory Information for ELIXOPHYLLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs ELIXOPHYLLIN theophylline CAPSULE;ORAL 085545-001 Jul 31, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-001 Jan 29, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Forest Labs ELIXOPHYLLIN theophylline CAPSULE;ORAL 083921-001 Jul 31, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs Inc ELIXOPHYLLIN theophylline SOLUTION, ELIXIR;ORAL 085186-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Forest Labs ELIXOPHYLLIN SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 086826-002 Jan 29, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Baxter
AstraZeneca
McKinsey
QuintilesIMS
Healthtrust
Federal Trade Commission
Covington
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot